Close Menu

NEW YORK (GenomeWeb) – PerkinElmer said after the close of the market on Wednesday that its third quarter revenues grew 22 percent year over year, paced by its diagnostics segment, which was up 59 percent.

For the three months ended Sept. 30, the company reported total revenues of $674.3 million, up from $554.3 million a year ago, but short of the consensus Wall Street estimate of $676.4 million.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

The Washington Post reports on researchers' efforts to determine the effect of an increasingly common SARS-CoV-2 mutation.

Florida Politics reports Florida's law barring life, long-term care, and disability insurers from using genetic information in coverage decisions went into effect at the beginning of July.

A new analysis finds a link between popular media coverage of a scientific study and how often that paper is cited.

In Nature this week: CRISPR approaches to editing plant genomes, way to speed up DNA-PAINT, and more.